Quantrx Biomedical (QTXB) Annual Balance Sheets

Annual · GAAP · USD millions
Access QTXB quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Quantrx Biomedical finances operations and invests in assets.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2021)
(Dec 31 2020) (Dec 31 2019) (Dec 31 2018) (Dec 31 2017)
Assets
Cash & cash equivalent0.01
Cash & Short-term Investments0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.00
Total Current Assets0.01
Long-term investments0.00
Other Assets, Noncurrent0.00
Total Assets0.01
Liabilities
Accounts Payable, Current AC0.01
Interest Payable, Current IN1.07
Notes Payable, Current NO1.39
Other Liabilities, Current0.00
Total Current Liabilities2.47
Total Long-term Debt0.00
Other liabilities, Noncurrent0.18
Total Liabilities2.65
Stockholders' Equity
Common Stock Value0.79
Additional Paid In Capital Common Stock48.88
Retained Earnings / Accumulated Deficit-52.38
Other Equity0.01
Common Stockholder's Equity-2.70
Preferred Stockholder's Equity0.06
Total Stockholder's Equity-2.64
Liabilities & Stockholder's Equity0.01
4 historic quarters locked

Sign in to unlock the full Quantrx Biomedical balance sheet history.

About Quantrx Biomedical Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-22-031830

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License